Evidence map›Paper›PMID 40708761›Full record

ArticleAdvances in medical education and practice2025

Capacity Building in Field Epidemiology in Sub Saharan Africa: Findings from Infectious Disease Field Epidemiology and Biostatistics in Africa (IDEA) Fellowship Program.

Jimmy Patrick Alunyo, George Paasi, Alex Riolexus Ario, Peter Olupot-Olupot, IDEA Fellowship Consortium, We acknowledge all the lead investigators of the IDEA Fellowship Consortium and their respective institutions for their valuable contributions to this work. Consortium partners include the Ministry of Science, Technology and Innovation, Uganda (MoSTI); Uganda National Health Research Organisation (UNHRO); Infectious Diseases Institute (IDI); Uganda National Health Laboratory Services (UNHLS); Uganda National Institute of Public Health (UNIPH); The Open University, United Kingdom; and Mbale Clinical Research Institute, Uganda.

Abstract read
In one paragraph

Article in Advances in medical education and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jimmy Patrick AlunyoDepartment of Community and Public Health, Busitema University, Mbale, Uganda.ORCID 0000-0002-7897-7730
George PaasiDepartment of Community and Public Health, Busitema University, Mbale, Uganda.
Alex Riolexus ArioUganda National Institute of Public Health, Kampala, Uganda.ORCID 0000-0002-3560-1952
Peter Olupot-OlupotDepartment of Community and Public Health, Busitema University, Mbale, Uganda.ORCID 0000-0002-5757-609X
IDEA Fellowship Consortium
We acknowledge all the lead investigators of the IDEA Fellowship Consortium and their respective institutions for their valuable contributions to this work. Consortium partners include the Ministry of Science, Technology and Innovation, Uganda (MoSTI); Uganda National Health Research Organisation (UNHRO); Infectious Diseases Institute (IDI); Uganda National Health Laboratory Services (UNHLS); Uganda National Institute of Public Health (UNIPH); The Open University, United Kingdom; and Mbale Clinical Research Institute, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Emerging and re-emerging infectious diseases (EREIDs) remain a major public health threat globally, particularly in sub-Saharan Africa (SSA), where fragile health systems, inadequate infrastructure, and limited workforce training exacerbate vulnerabilities. Uganda, a recognised hotspot for outbreaks, faces increasing risk due to anthropogenic and environmental drivers. To address critical capacity gaps, the Infectious Disease Epidemiology and Biostatistics in Africa (IDEA) Fellowship was launched as Uganda's first master's-level programme in infectious disease field epidemiology. Led by Busitema University, in collaboration with national and international partners, the programme was funded through EDCTP-II (CSA2020E). Methods: The IDEA Fellowship combined theoretical instruction with fieldwork and research tailored to national health priorities. Activities included outbreak investigations, disease modelling, and surveillance, supported by Africa CDC, Uganda's Ministry of Health, and UK institutions. A REDCap-based survey was administered to 202 public health professionals across SSA to assess training needs, skill gaps, and barriers. Data were analysed using descriptive statistics and thematic analysis. Results: The programme trained 15 master 's-level fellows, strengthening Uganda's capacity in surveillance, early detection, and outbreak response. Survey results showed that 55.4% of professionals required further training, with skill gaps in zoonotic disease management (64.4%), outbreak preparedness (64.9%), and data management (59.4%). Key barriers included limited diagnostic capacity (73.8%) and weak collaboration (49.5%). Qualitative findings highlighted inconsistent mentorship, restricted data access, and limited funding for fieldwork. Respondents advocated for structured mentorship, longer training durations (≥3-6 months), and hybrid delivery models (42.3%). Conclusion: The IDEA Fellowship demonstrates a scalable model for infectious disease capacity building in SSA. Training African scientists in local contexts promotes relevance, retention, and cost-effectiveness. Regional expansion, cross-sector collaboration, and systemic investment are essential for sustainable epidemic preparedness and global health security.

Indexed as

capacity buildingfield epidemiologyinfectious disease trainingSub-Saharan Africa

Identifiers

PMID40708761
PMCPMC12288224

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.